Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 87 Total
ADPT - Adaptive Biotechnologies Corp - Stock Price Chart
CompanyAdaptive Biotechnologies Corp
Market Cap436.72MEPS (ttm)-1.56
P/E-EPS this Y16.03%
Forward P/E-EPS next Y17.65%
PEG-EPS past 5Y-32.91%
P/S2.56EPS next 5Y21.60%
P/B1.42EPS Q/Q-70.84%
Dividend-Sales Q/Q-17.05%
Insider Own4.54%Inst Own95.41%
Insider Trans-2.68%Inst Trans-3.09%
Short Float6.57%EarningsFeb 14/a
Analyst Recom1.50Target Price6.67
Avg Volume1.50M52W Range2.53 - 9.08
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NEUPERT PETER MDirectorMar 12 '24Option Exercise0.8415,00012,600169,296Mar 13 05:55 PM
ROBINS CHAD MCEO and ChairmanMar 05 '24Sale3.4348,673167,0072,576,701Mar 06 07:40 PM
RUBINSTEIN JULIEPresidentMar 05 '24Sale3.4739,070135,764472,754Mar 06 07:41 PM
BENZENO SHARONChief Commercial Ofc Imm MedMar 05 '24Sale3.4429,390100,994327,415Mar 06 07:42 PM
PETERSON TYCHOChief Financial OfficerMar 05 '24Sale3.4415,45653,169531,553Mar 06 07:40 PM
SWIN - Solowin Holdings - Stock Price Chart
CompanySolowin Holdings
CountryHong Kong
IndustryCapital Markets
Market Cap152.25MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own82.76%Inst Own0.01%
Insider Trans0.00%Inst Trans-
Short Float4.90%Earnings-
Analyst Recom-Target Price-
Avg Volume464.76K52W Range1.84 - 72.55
Solowin Holdings engages in the provision of securities brokerage solutions through its subsidiary. It operates through the following segments: Securities Related Services, Investment Advisory Services, Asset Management Services, and Corporate. The Securities Related Services segment is involved in offering securities dealing and brokerage services, securities underwriting and placing services, and other financing services. The Investment Advisory Services segment offers investment solutions advisory services for clients, through a team consists of financial analysts, financial advisors, and investment managers. The Asset Management Services segment specializes in designing investment portfolios for investors with different risk appetite and to preserve the value of assets. The company was founded on July 23, 2021 and is headquartered in Hong Kong.
CUTR - Cutera Inc - Stock Price Chart
CompanyCutera Inc
IndustryMedical Devices
Market Cap44.11MEPS (ttm)-7.58
P/E-EPS this Y-3.56%
Forward P/E-EPS next Y38.88%
PEG-EPS past 5Y-27.69%
P/S0.21EPS next 5Y25.00%
P/B-EPS Q/Q-471.58%
Dividend-Sales Q/Q-26.45%
Insider Own5.09%Inst Own87.16%
Insider Trans0.00%Inst Trans-0.93%
Short Float40.89%EarningsMar 21/a
Analyst Recom2.20Target Price6.33
Avg Volume1.18M52W Range1.28 - 24.71
Apr-11-24 08:00AM Cutera Announces the North America Launch of xeo+ (Business Wire) +10.29%
Mar-28-24 01:38PM 15 Best Beauty Stocks To Invest In (Insider Monkey) +5.76%
Mar-22-24 11:40AM Cutera, Inc. (NASDAQ:CUTR) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.43%
07:07AM Q4 2023 Cutera Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-21-24 08:53PM CUTR Stock Earnings: Cutera Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +9.00%
06:00PM Cutera: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook (Business Wire)
Mar-06-24 01:52PM CUTR Stock Earnings: Cutera Misses EPS, Misses Revenue for Q3 2023 (InvestorPlace)
Mar-05-24 07:17PM Cutera: Q3 Earnings Snapshot (Associated Press Finance)
Mar-01-24 08:30AM Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024 (Business Wire) +7.59%
Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harris Taylor C.Chief Executive OfficerAug 29 '23Buy9.9130,000297,300279,336Aug 30 08:57 AM
Drummond StuartInterim CFOAug 29 '23Buy9.805,00049,00019,678Aug 30 08:56 AM
MARPS - Marine Petroleum Trust - Stock Price Chart
CompanyMarine Petroleum Trust
IndustryOil & Gas Midstream
Market Cap10.80MEPS (ttm)0.45
P/E11.93EPS this Y14.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y15.80%
P/S9.00EPS next 5Y-
P/B10.76EPS Q/Q-47.40%
Dividend7.76%Sales Q/Q-25.00%
Insider Own19.00%Inst Own3.50%
Insider Trans0.00%Inst Trans-15.61%
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume7.47K52W Range3.94 - 7.92
Marine Petroleum Trust, together with its subsidiary, Marine Petroleum Corporation, operates as a royalty trust in the United States. It has overriding royalty interest in oil and natural gas leases in the Central and Western areas of the Gulf of Mexico off the coasts of Louisiana and Texas. Marine Petroleum Trust was founded in 1956 and is based in Dallas, Texas.
HNRA - HNR Acquisition Corp - Stock Price Chart
CompanyHNR Acquisition Corp
IndustryOil & Gas Integrated
Market Cap13.68MEPS (ttm)-0.03
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.47EPS Q/Q86.79%
Dividend-Sales Q/Q-
Insider Own50.26%Inst Own9.68%
Insider Trans0.00%Inst Trans2.69%
Short Float0.83%Earnings-
Analyst Recom-Target Price-
Avg Volume348.54K52W Range1.36 - 13.93
Pogo Resources LLC engages in the acquisition, development, exploration, production, and divestiture of oil and natural gas properties in the Permian Basin. The company was founded in February 2017 and is headquartered in Dallas, TX.
URGN - UroGen Pharma Ltd - Stock Price Chart
CompanyUroGen Pharma Ltd
Market Cap515.21MEPS (ttm)-3.72
P/E-EPS this Y-2.81%
Forward P/E-EPS next Y47.07%
PEG-EPS past 5Y5.89%
P/S6.23EPS next 5Y-
P/B-EPS Q/Q41.19%
Dividend-Sales Q/Q30.06%
Insider Own15.70%Inst Own72.01%
Insider Trans-0.39%Inst Trans-0.56%
Short Float14.55%EarningsMar 14/b
Analyst Recom1.40Target Price38.50
Avg Volume350.64K52W Range8.69 - 24.13
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoenberg MarkChief Medical OfficerMar 18 '24Sale14.0512,000168,600139,437Mar 20 04:38 PM
Smith Jason DrewGeneral CounselJan 31 '24Sale15.744,99378,59018,824Feb 02 07:12 PM
Schoenberg MarkChief Medical OfficerJan 31 '24Sale15.743,78959,639149,423Feb 02 07:07 PM
Smith Jason DrewGeneral CounselAug 31 '23Sale18.013,80068,43818,407Sep 05 04:28 PM
HGAS - Global Gas Corp - Stock Price Chart
CompanyGlobal Gas Corp
IndustrySpecialty Chemicals
Market Cap20.43MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q112.14%
Dividend-Sales Q/Q-
Insider Own88.53%Inst Own6.62%
Insider Trans0.00%Inst Trans106.82%
Short Float2.05%Earnings-
Analyst Recom-Target Price-
Avg Volume23.36K52W Range1.36 - 10.66
Global Gas Corporation engages in the development and supply of nascent pure-play hydrogen, carbon and industrial gas. The company is headquartered in New York, NY.
PMVP - PMV Pharmaceuticals Inc - Stock Price Chart
CompanyPMV Pharmaceuticals Inc
Market Cap92.08MEPS (ttm)-1.44
P/E-EPS this Y4.17%
Forward P/E-EPS next Y-3.04%
PEG-EPS past 5Y-28.63%
P/S-EPS next 5Y23.10%
P/B0.41EPS Q/Q27.64%
Dividend-Sales Q/Q-
Insider Own20.87%Inst Own85.41%
Insider Trans-0.81%Inst Trans-5.35%
Short Float6.39%EarningsFeb 29/a
Analyst Recom1.40Target Price5.67
Avg Volume562.66K52W Range1.17 - 9.72
Apr-12-24Initiated Jefferies Buy $5
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORBIMED ADVISORS LLC10% OwnerNov 22 '23Sale2.2387,786195,7630Nov 24 04:38 PM
Mack David HenryPresident and CEOOct 18 '23Option Exercise0.53198,407105,156363,877Nov 13 04:21 PM
Alland LeilaChief Medical OfficerSep 15 '23Sale6.626,29141,64645,909Sep 18 04:22 PM
Jalota DeepikaChief Development OfficerSep 15 '23Sale6.624,10427,16829,946Sep 18 04:26 PM
Mack David HenryPresident and CEOAug 07 '23Option Exercise0.5385,50045,315165,470Aug 08 04:43 PM
LYEL - Lyell Immunopharma Inc - Stock Price Chart
CompanyLyell Immunopharma Inc
Market Cap764.84MEPS (ttm)-0.94
P/E-EPS this Y8.52%
Forward P/E-EPS next Y-5.12%
PEG-EPS past 5Y-15.28%
P/S5883.39EPS next 5Y-7.90%
P/B1.17EPS Q/Q-522.32%
Dividend-Sales Q/Q-99.97%
Insider Own53.66%Inst Own27.92%
Insider Trans0.00%Inst Trans4.25%
Short Float15.38%EarningsFeb 29/b
Analyst Recom1.67Target Price6.67
Avg Volume901.66K52W Range1.32 - 3.97
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Klausner RichardDirectorAug 15 '23Sale2.2858,020132,286930,880Aug 17 04:23 PM
RYDE - Ryde Group Ltd. - Stock Price Chart
CompanyRyde Group Ltd.
IndustrySoftware - Application
Market Cap48.42MEPS (ttm)-0.24
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S6.26EPS next 5Y-
P/B-EPS Q/Q-49.14%
Dividend-Sales Q/Q52.36%
Insider Own59.60%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume281.13K52W Range2.02 - 8.12
Ryde Group Ltd. provides mobility and quick commerce solutions to its consumers through its subsidiaries. The company was founded on February 21, 2023 and is headquartered in Singapore.